Organization · Venture Capital
Lumira Ventures
Lumira Ventures is a North American venture capital firm specializing in healthcare and life sciences, investing in innovative therapeutics and medical technologies. The firm is based in Toronto with additional offices in Montréal, Vancouver, and Boston.
Overview
What Lumira Ventures does
What Lumira Ventures is
Lumira Ventures is a North American venture capital firm specializing in healthcare and life sciences, investing in innovative therapeutics and medical technologies. The firm is based in Toronto with additional offices in Montréal, Vancouver, and Boston.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2007
- Approximate age
- About 19 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Lumira Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Lumira Ventures as a funder
Investment thesis
Lumira Ventures focuses on investing in transformative life sciences companies that develop and commercialize impactful products for patients, targeting high unmet clinical needs to enhance patient outcomes and reduce healthcare costs.
Focus narrative
Lumira Ventures invests in therapeutic products and medical devices, targeting a broad range of therapeutic areas with high unmet clinical needs. The firm supports companies from early-stage therapeutics to late clinical and revenue-generating medical devices, aiming to enhance patient outcomes and create inclusive healthcare solutions.
Value beyond capital
Lumira Ventures adds value to its portfolio companies through strategic partnerships, access to a broad network of institutional investors, and expertise in navigating the life sciences landscape, enhancing their ability to commercialize innovative healthcare solutions.
Terms and economics
- Typical check
- $1,000,000–$220,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Endotronix, OpSens Medical, Bardy, and Engage Therapeutics
Portfolio context
Notable portfolio companies include: Endotronix, a leader in heart failure management solutions; OpSens Medical, a pioneer in fiber optic sensing technology for coronary artery disease; Bardy, which developed a patient-friendly cardiac monitoring solution; Engage Therapeutics, creator of the first on-demand treatment for active epileptic seizures; Aurinia Pharmaceuticals, known for the first oral therapy for lupus nephritis; Zymeworks, focusing on bi-specific antibodies for cancer treatment; and G1 Therapeutics, developing therapies for oncology.
Common questions
What to know about Lumira Ventures
Upseed classifies Lumira Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.